ER+ HER2- advanced breast cancer

Clinical trials for ER+ HER2- advanced breast cancer explained in plain language.

Never miss a new study

Get alerted when new ER+ HER2- advanced breast cancer trials appear

Sign up with your email to follow new studies for ER+ HER2- advanced breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New pill could offer hope for advanced breast cancer patients

Disease control Completed

This Phase 3 trial compares a new hormone therapy pill called elacestrant to standard treatments (fulvestrant or aromatase inhibitors) in 478 people with ER+/HER2- advanced breast cancer that worsened after prior CDK4/6 inhibitor therapy. The study measures how long the cancer st…

Matched conditions: ER+ HER2- ADVANCED BREAST CANCER

Phase 3 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control

Last updated Jun 26, 2026 17:03 UTC

ER+ HER2- advanced breast cancer

Get alerted when new ER+ HER2- advanced breast cancer trials appear

New pill could offer hope for advanced breast cancer patients